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ABSTRACT 
Dendrimers are hyper-branched macromolecules having tree like structure, consisting of a core molecule and alternating layers of 
monomers. Due to their unique architecture these have improved physical and chemical properties like high solubility, miscibility 
and reactivity.  Dendrimers consist of well defined size, shape, molecular weight and monodispersity. These properties formulate 
the dendrimers a suitable carrier in drug delivery application. These are built from number of molecular entities of colloidal 
particles that exists in equilibrium with the molecules or ions in nature and due to these increases the solubility of poorly soluble 
drugs. Dendrimers have the ability to encapsulate and bind the guest molecule can be used for solubility enhancement, sustained 
release and various drug delivery applications. The terminal groups are modified to attach biologically active substances for 
targeting purpose. Dendrimers are suitable for a wide range of targeted drug delivery, controlled drug delivery, gene delivery and 
industrial applications. This review gives concise information about the dendrimers, its synthesis, characterization and application 
in drug delivery.  
Keywords: Dendrimers, drug delivery, monomers, solubility enhancement. 
 
INTRODUCTION 
At present scenario many researchers are working to 
deliver the drug with improved bioavailability, 
enhancement in solubility, to hit the target site to 
produce therapeutic effects, and to avoid the toxic 
effects
1
.  Dendrimers is one out of many approaches 
which focuses on the above criteria. These are hyper-
branched, globular, monodisperse, three dimensional 
nanoscale synthetic polymers, having very well defined 
size, shape and definite molecular weight having high 
degree of surface functionality and versatility
2
. 
The term “Dendrimer” derived from two Greek words 
“Dendron” meaning tree “Meros” meaning part. The 
chemistry of dendrimers was introduced in 1978 by 
Fritz Vogtle and co-workers. Dendrimers used as a 
polymeric material. Dendrimers differs from traditional 
polymers in that they have a multi-branched, three 
dimensional architecture with very low polydispersity 
and high functionality
3
.  
In dendritic structures number of terminal group 
increases exponentially with a linear increase in the 
generation of dendrimer. This relationship limits the 
ultimate size of the dendrimer due to steric crowding of 
the terminal groups. Dendrons is the term used about a 
dendritic wedge without a core, the Dendrimer can be 
prepared from assembling two or more dendrons. As 
we shall see later, dendrons are very useful tools in the 
synthesis of dendrimers by the segment coupling 
strategy. These dendrons have been used in the creation 
of numerous of dendrimers having different structures 
and functions. The dendrimer shell is the homo-
structural spatial segment between the focal points, the 
“generation space”. 
 
 
  Figure 1: (a) Dendrimers                    (b). Dendron 
 
The “outer shell” is the space between the last outer 
branching point and the surface. The “inner shells” are 
generally referred to as the dendrimer interior
4
. 
In dendrimers, the outer shell consists of a varying 
number of pincers created by the last focal point before 
reaching the dendrimer surface.  
Advantages 
1. Low polydispersity index  
Due to stringent control during synthesis, they have 
lower polydispersity index. As the density of branches 
increases the outer most branches arrange themselves 
surrounding a lower density core in the form of spheres 
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and outer surface density is more and most of the space 
remains hollow towards core. This region is utilized for 
drug entrapment
5
. 
2. Improved permeability  
Dendrimers can cross bio barriers like blood brain 
barrier, cell membrane. Dendrimers might show an 
enhanced permeability and retention effect which 
allows them to target tumour cells more effectively 
than small molecules
6
. 
3. Improved loading capacity  
Drug can get entrapped inside the internal cavities as 
well as electro statically in the surface of dendrimers. 
Dendrimers structures can be used to load and store a 
wide range of organic or inorganic molecules by 
encapsulation and absorption on surface
7
.  
4. Higher Solublization Potential  
Dendrimers improves the solubility, biodistribution, 
and efficacy of a number of therapeutics as well as 
being used as imaging and diagnostic molecules in 
animal models bearing brain tumors. Probable 
mechanism includes ionic interaction, hydrogen 
bonding and hydrophobic interactions
8
.  
5. Increased permeability and retention effect  
Dendrimers might show an enhanced permeability and 
retention effect (depending on their M.W) that allows 
them to target tumor cells more effectively than small 
molecules
9
.  
6. High stability  
Dendrimers have nanoscopic particle size range from 1 
- 100 nm, which makes them less susceptible for 
reticulum endothelium uptake. Dendrimers drug 
complex or conjugate shows better colloidal, biological 
and shelf-stability
10
.  
7. High uniformity and purity  
Dendrimers have uniform sizes range, well defined 
surface functionality, and negligible impurity.  
8. Low immunogenicity  
Dendrimers shows low or negligible immunogenic 
response when injected or used topically. The problems 
as found in vesicular system like chemical instability, 
drug leakage, aggregation and fusion during storage, 
solubility in physiological environment, lysis of 
phospholipids, purity of natural phospholipids are not 
present in dendritic system  
9. Sustained/ extended effect  
Dendrimers releases drug in a sustained manner.  
10. Multifunctional platform  
Multiple functional groups are present on outer surface 
of dendrimers, which can be used to attach vector 
devices for targeting to particular site in the body.  
Terminal groups may also be modified to reorganize 
specific receptors. The surface modification may allow 
designing dendrimers mimicking biological exo-
receptors, substrates, inhibitors or cofactors
11
.  
11.  Low toxicity  
Most dendrimers systems display very low cytotoxicity 
levels but have good biodegradability.  
Types of Dendrimers  
1. Poly amidoamine dendrimers (PAMAM) 
 Dendrimers: PAMAM dendrimers represent an 
exciting new class of macromolecular architecture 
called "dense star" polymers. They have two-
dimensions, star like pattern. These are synthesized by 
the divergent method starting from ammonia or 
ethylenediamine initiator core reagents. These 
dendrimers are commercially available, usually as 
methanol solutions
12
.  
2. Hybrid dendrimers 
Hybrid dendrimers are hybrids of dendritic and linear 
polymers. These are obtained by complete mono 
functionalization of the peripheral amines of a "zero-
generation" polyethyleneimine dendrimer, provide 
structurally diverse lamellar, columnar, and cubic self 
organized lattices that are less readily available from 
other modified dendritic structures
13
. 
3. Fréchet dendrimers  
It is a more recent type of dendrimer based on poly-
benzyl ether hyper branched skeleton. These 
dendrimers usually have carboxylic acid groups as 
surface groups, serving as a good anchoring point for 
further surface functionalization, and as polar surface 
groups to increase the solubility of this  hydrophobic 
dendrimer type in polar solvents or aqueous media
14
.  
4. Tecto dendrimers  
These are composed of a core dendrimer, surrounded 
by dendrimers of several steps (each type design) to 
perform a function necessary for a smart therapeutic 
nanodevice. Different compounds perform varied 
functions ranging from diseased cell recognition, 
diagnosis of disease state drug delivery, reporting 
location to reporting outcomes of therapy
15
.  
5. Chiral dendrimers 
The chirality in these dendrimers is based upon the 
construction of constitutionally different but 
chemically similar branches to chiral core. Their 
potential use includes as chiral hosts for enantiomeric 
resolutions and as chiral catalysts for asymmetric 
synthesis
16
. 
6. Multiple antigen peptide dendrimers  
It is a dendron-like molecular construct based upon a 
polylysine skeleton. Lysine with its alkyl amino side-
chain serves as a good monomer for the introduction of 
numerous of branching points. This type of dendrimer 
used in biological applications, e.g. vaccine and 
diagnostic research
17
.  
7. Micellar dendrimers 
Micellar dendrimers are unimolecular water soluble 
hyper branched polyphenylenes micelles. 
8. Amphiphilic dendrimers  
They are built with two segregated sites of chain end, 
one half is electron donating and the other half is 
electron withdrawing
18
.  
9. Propylene Imine (PPI) dendrimers  
These dendrimers are generally poly-alkyl amines 
having poly-alkyl amines as end groups, and numerous 
tertiary trispropylene amines present in interior portion.  
PPI dendrimers are commercially available up to G5, 
and has found widespread applications in material 
science as well as in biology
19
. 
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10. Poly amidoamineorganosilicon (PAMAMOS) 
dendrimers 
These are radially layered poly(amidoamine-
organosilicon) dendrimers (PAMAMOS) having 
inverted unimolecular micelles that consist of 
hydrophilic, nucleophilic polyamidoamine (PAMAM) 
interiors and hydrophobic organosilicon (OS) exteriors. 
These are excellent in  networks regularity and have 
ability to complex and encapsulate various guest 
species offer unprecedented potentials for new 
applications in nanolithography, lectronics, 
photonics, chemical catalysis etc. These dendrimers are 
exceptionally useful precursors for the preparation of 
honeycomb-like networks with nanoscopic PAMAM 
and OS domains
20
. 
 
PROPERTIES OF DENDRIMERS  
1. Size and shape 
Dendrimers shows improved physical and chemical 
properties due to their molecular architecture. The 
dendrimers shape depend on the generation i.e. lower 
generation shows open planar elliptical shape while 
higher generation shows compact-spherical shape. 
Inherent structural defects exist when synthesizing 
high-generation dendrimers. The reasons include 
incomplete reactions and steric resistance, which cause 
the missing of repeating units, intramolecular 
cyclization, dimmer formation and retro- Michael 
reaction in dendrimers.  Due to their nanometric scales 
and other properties that are similar to proteins, 
dendrimers are also known as artificial proteins. The 
dendrimer can be controlled by molecular engineering 
so that its size resembling to antibodies, enzymes and 
globular proteins
21
.  
2. Monodispersivity  
The monodispersion means that the dendrimers has a 
well defined molecular structure and without large 
individual variations, in other words, they are 
homogeneous unlike other polymers due to their 
controlled synthesis and purification processes.  
Dendrimers are monodisperse in nature i.e. they have 
isomolecular species, whose molecular size, shape and 
disposition of organic moieties are adjusted and 
controlled.  Monodisperse property of dendrimers has 
already been extensively characterized by high 
performance liquid chromatography, size exclusion 
chromatography, mass spectrometry, gel 
electrophoresis, and transmission electron 
microscopy
22
.  
3. Polyvalency  
It shows the outer arrangement of reactive groups on 
the exterior of dendrimer nanostructure. Polyvalency it 
provides for versatile functionalization; it produce 
multiple interactions with biological receptor sites, for 
example, in the design of antiviral therapeutic agents.  
The polivalency is related to the quantity of reactive 
sites on outside of the dendrimer potential to form 
connections with various materials of interest. The 
multivalencyallows better interaction with biological 
targets since most of the molecular interactions occur 
through biological multivalent bonds
23
. 
4. Solubility and biocompability  
The solubility of dendrimers is determined by the 
surface functional groups, dendrimer generation, 
repeated units, and even the core.  Generally 
dendrimers have greater solubility in common solvents 
as compared to linear polymers.  If the surface end 
groups are hydrophobic in nature, then dendrimers are 
soluble in nonpolar solvent. If the surface end groups 
are hydrophilic in nature and dendrimers are soluble in 
polar solvent
24
.  
5. Toxicity  
Some dendrimer systems display very low toxicity 
levels – with dendrimers carrying anionic groups being 
less toxic than those carrying cationic groups. 
Dendrimers may cause toxicity mainly attributed to the 
interaction of the cationic dendrimers surface with 
negative biological load membranes damaging cellular 
membranes causing hemolytic toxicity and 
cytotoxicity. Therefore, PAMAM dendrimers are more 
cationic than anionic cytotoxic. Many toxic effects of 
dendrimers are attenuated at their surfaces with 
hydrophilic molecules and poly (ethylene glycol) 
(PEG) which masks the surface charge cationic 
dendrimers improving biocompatibility and increasing 
the solubility of the polymers
25
.  
6. Drug and dendrimers interactions  
Dendrimers interact with drug molecules physically by 
absorption on surface by electrostatic interactions or by 
conjugation with the surface groups for covalent 
bonding or by encapsulation of the drug into the 
cavities of the dendrimers. In most cases, however, the 
conjugated dendritic assembly functions as pro-drug 
„where, upon internalization into the target cell, the 
conjugate must be liberated to activate the drug.  
7. Viscosity  
In solution dendrimers form a tightly packed ball, 
which influences its rheological properties. The 
intrinsic viscosity dendrimers solution does not exhibit 
linear relationship with mass
26
. 
8. Immunogenicity 
It is one of the crucial biological properties of the 
dendrimers. As per research, unmodified amino 
terminated PAMAM dendrimers are presenting no or 
only weak immunogenicity of the G3–G7. PAMAM 
dendrimers with polyethylene glycol chains decrease 
immunogenicity and offers longer lifetime in the blood 
stream in comparison to un-modified dendrimers. 
9. Loading capacity (molecular container property)  
This property makes dendrimers very suitable as drug 
delivery vehicles and also appropriate for obtaining 
electro-optic or magnetic devices. In addition to 
carrying materials on their surface, the internal cavities 
of dendritic structures can be used to carry and/ or store 
a wide range of metals, organic, or inorganic molecules 
by encapsulation and absorption. The appropriate type 
(and degree) of functionalisation will results in the 
desired loading capacity
27
.  
 
METHODS OF SYNTHESIS 
There are two different methods of dendrimer 
synthesis, divergent synthesis and convergent synthesis  
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1. Divergent Method 
In this method, dendrimers grows outwards from the 
focal core, using a pair of basic operations that consist 
of  coupling of building blocks, and de protection or 
modification of end functionalities of the periphery to 
create new reactive surface functionalities; this pair of 
basic operations is often referred to as the growth of a 
generation. Each step of the reaction must be 
determined to full completion to prevent mistakes in 
the dendrimer, which can grounds trailing generations 
(some branches are shorter than the others). This 
process is repeated until the desired number of 
generations is obtained. 
In this method very large dendrimers get prepared.  
Problems occur from side reactions and incomplete 
reactions of the end groups that lead to structure 
defects. To minimize these side reactions and 
imperfections, it‟s recommended to use a large excess 
of reagents
28
. 
 
Figure 2: The divergent method 
 
2. Convergent Method 
It is an alternative method to the divergent approach for 
producing precisely controlled dendritic architectures.  
The convergent approach overcomes some of the 
problems associated with the divergent method. In the 
convergent approach, the dendrimer is constructed 
stepwise. Starting from the end groups and progressing 
inwards. When the growing branched polymeric arms, 
called dendrons, are large enough, they are attached to 
a multifunctional core molecule. 
 
Figure 3: The convergent method 
 
 This method makes it very much easier to eliminate 
impurities and shorter twigs along the way, so that the 
final dendrimer is more mono-disperse. The convergent 
approach does not allow the formation of high 
generations because steric problems occur in the 
reactions of the dendrons and the core molecule. 
Reactions under a convergent approach need a 
relatively longer time compared to that of the divergent 
method
29
. 
Factors affecting dendrimers synthesis 
There are different factors which can affect dendrimer 
synthesis. The non-ideal dendrimer 
expansion may be manifested through a variety of 
ways which includes: 
1. Incomplete addition reaction. 
2. Intermolecular cyclization. 
3. Fragmentation. 
4. Solvolysis of terminal functionalities. 
 
APPLIAPPLICATIONS OF DENDRIMERS 
Specific properties such as unparalled molecular 
uniformity, multifunctional surface and presence of 
internal cavities makes dendrimers suitable for a 
variety of high technology uses and are as follows: 
(A) PHARMACEUTICAL APPLICATIONS 
1. Dendrimers in ocular drug delivery  
The nanosize, ease of preparation, functionalization, 
and possibility to attach multiple surface groups 
renders dendrimers as suitable alternative vehicle of 
ophthalmic drug delivery. 
 PAMAM dendrimers with carboxylic or hydroxyl 
surface groups, improves residence time and enhance 
bioavailability of pilocarpine in the eye. Also some of 
the phosphorus containing dendrimerswith quaternary 
ammonium core and terminal carboxylic groups has 
successfully reported for ocular drug delivery of 
carteolol
32
. 
2. Dendrimers in pulmonary drug delivery
 
Dendrimers have also been reported for pulmonary 
drug delivery as well. A previous study was performed, 
by measuring plasma anti-factor Xa activity using 
PAMAM dendrimers in enhancing pulmonary 
absorption of Enoxaparin, and by observing prevention 
efficacy of deep vein thrombosis in a rodent model. it 
was observed that G2 and G3 generation positively 
charged PAMAM dendrimers increased the relative 
bioavailability of Enoxaparin by 40% while G2.5 
PAMAM half generation dendrimers containing 
negatively charged carboxylic groups had no effect
33
.  
3. Dendrimers in transdermal drug delivery 
Dendrimers may improve drug properties such as 
solubility and plasma circulation time via transdermal 
formulations and to deliver drugs efficiently due to it‟s 
highly water soluble and biocompatible nature. The 
viscosity imparting property of a dendrimer solution 
allows for ease of handling of highly concentrated 
dendrimer formulations for these applications. Drug 
permeation can be improved through the skin when 
PAMAM dendrimer complex with NSAIDs like 
ketoprofen, diflunisal and enhanced bioavailability of 
PAMAM dendrimers by using indomethacin as the 
model drug in transdermal drug application
29
. 
4. Dendrimers as Nano-Drugs  
Dendrimers as nano-Drugs, useful as antiviral drugs 
against the herpes simplex virus can potentially 
prevent/reduce transmission of HIV and other sexually 
transmitted diseases (STDs) when poly (lysine) 
dendrimers modified with sulfonated naphthyl groups.  
5. Dendrimers for controlled release drug delivery 
Encapsulation of 5-fluorouracil into PAMAM 
dendrimers(G=4) modified with carboxy methyl 
PEG5000 surface chains revealed reasonable drug 
loading, a reduced release rate and reduced haemolytic 
toxicity. Controlled release of the Flurbiprofen 
achieved by formation of complex with amine 
terminated generation 4 (G4) PAMAM dendrimers
26
. 
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6. Dendrimers in oral drug delivery 
Oral drug delivery studies using the human colon 
adenocarcinoma cell line, which have indicated that 
low generation PAMAM dendrimers cross cell 
membrane through a combination of two processes, i.e. 
paracellular transport and adsorptive endocytosis. 
Increase in the cytotoxicity and permeation of 
dendrimers when increase in the concentration and 
generation
28
. 
7. Dendrimers as bio mimetic artificial proteins 
Dendrimers are often referred to as “artificial proteins” 
due to their dimensional length scaling, narrow size 
distribution, and other bio mimetic properties. For 
examples PAMAM family, they closely match the 
sizes and contours of many important proteins and bio 
assemblies like insulin (3 nm), cytochrome C (4 nm), 
and haemoglobin (5.5 nm) are approximately the same 
size and shape as ammonia-core PAMAM dendrimers 
generations 3, 4 and 5, respectively.  
8. Dendrimers as solubility enhancer 
Dendrimers are unimolecular micellar nature, due to 
have hydrophilic exteriors and hydrophilic interiors 
and form covalent as well as non-covalent complexes 
with drug molecules and hydrophobes, and enhance its 
solubilisation behaviour. Water soluble dendrimers are 
capable of binding and solubilizing small acidic 
hydrophobic molecules with antifungal or antibacterial 
propertiesThese characteristic offers the opportunity to 
soluble poorly soluble drugs by encapsulating them 
within the dendritic structure not have a critical micelle 
concentration
29
.  
9. Dendrimers in targeted drug delivery 
Dendrimers have attracted the most attention as 
potential drug delivery scaffolds due to their unique 
characteristics. Dendrimers can be used to deliver 
drugs either by encapsulating the drug in the dendrimer 
interior void spaces or by conjugation to surface 
functionalities. Dendrimers have ideal properties which 
are useful in targeted drug-delivery system. For 
example PAMAM dendrimers conjugated with the 
folic acid and fluorescein isothiocyanate for targeting 
the tumor cells and imaging respectively
30
. 
10. Dendrimers in targeted gene delivery 
Dendrimers are extensively used as non-viral vector for 
gene delivery. They can work as carriers, called 
vectors, in gene therapy. Vectors transfer genes 
through the cell membrane into the nucleus. Various 
polyatomic compound such as PEI, polylysine, and 
cationic have been utilized as non-viral gene carrier. 
PAMAM dendrimers have also been tested as genetic 
material carriers. Cationic dendrimers 
(Polypropylenimine (PPI) dendrimer) deliver genetic 
materials into cells by forming complexes with 
negatively charged genetic materials through 
electrostatic interaction.  Furthermore, dendrimers are 
non-immunogenic and are thus uniquely suited as 
carrier structures for drugs or bioactive molecules 
without degradation in immune system
31
. 
 
 
 
(B) THERAPEUTIC APPLICATION 
1. Dendrimers in anticancer drug delivery 
 One of the major applications of dendrimers is as a 
delivery vehicle for various anticancer drugs. The 
structure and tunable surface functionality of 
dendrimers allows for the encapsulation/conjugation of 
multiple entities, either in the core or on the surface, 
rendering them ideal carriers for various anticancer 
drugs.  This dendritic nano-formulation, which 
contains doxorubicin covalently bound through a 
hydrazone linkage to a high molecular weight three-
arm polyethylene oxide; exhibits reduced cytotoxicity 
in-vitro.  In an attempt to improve the efficacy of 
doxorubicin, Lai et al utilize photochemical 
internalization (PCI) technology for site-specific 
delivery of membrane impermeable macromolecules 
from endocytic vesicles into the cytosol.  Many 
investigators have also explored the feasibility of 
cisplatin incorporation in dendrimers
32
.  
2. Dendrimers for boron neutron capture therapy  
The radiation energy generated from the capture 
reaction of low-energy thermal neutrons by 10B atoms 
has been used successfully for the selective destruction 
of tissue.  
This radiation energy has been used successfully for 
the selective destruction of tissue. Dendrimers are a 
very fascinating compound for use as boron carriers 
due to their well defined structure and multivalency
33
. 
(C) DIAGNOSTIC APPLICATIONS 
1. Dendrimers as molecular probes  
Dendrimers are fascinating molecules to use as 
molecular probes because of their distinct morphology 
and unique characteristics. For Example, the 
immobilization of sensor units on the surface of 
dendrimers is a very efficient way to generate an 
integrated molecular probe, because of their large 
surface area and high density of surface 
functionalities
34
. 
2. Dendrimers as X-ray contrast agents  
Dendrimers are currently under investigation as 
potential polymeric X-ray contrast agents. Potential 
dendritic X-ray contrast agents using various organo 
metallic complexes such as bismuth and tin are used to 
obtain a high resolution X-ray image, several diseases 
or organs, such as arteriosclerotic vasculature, tumors, 
infarcts, kidneys or efferent urinary etc. In a study 
Krause and co-workers synthesized a number of 
potential dendritic X-ray contrast agents using various 
organo metallic complexes such as bismuth and tin
35
. 
3. Dendrimers as MRI contrast agents  
A number of research groups have explored the use of 
dendrimers as a new class of high molecular weight 
MRI contrast agents. Introduction of target specific 
moieties to the dendritic MRI contrast agents, to 
improve the pharmacokinetic properties of dendrimer 
contrast agents, for example folate conjugated Gd 
(III)–DTPA PAMAM dendrimer, which increased the 
longitudinal relaxation rate of tumor cells expressing 
the high affinity folate receptor. In a study Wiener et al  
synthesized a folate conjugated Gd(III)–DTPA 
PAMAM dendrimers, which increased the longitudinal 
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relaxation rate of tumor cells expressing the high 
affinity folate receptor
36
. 
 
CONCLUSION 
 Present review discussed very elaborately about 
characterization techniques and applications of 
dendrimers. The dendrimers have a promising future in 
various pharmaceutical applications and diagnostic 
field in the coming years as they possess unique 
properties, such as high degree of branching, multi 
valency, globular architecture and well defined 
molecular weight, there by offering new scaffolds for 
drug delivery. They provide platforms for drug 
attachment and have the ability to encapsulate or bind 
drugs via several mechanisms. At present many drugs 
are facing problems of poor solubility, bioavailability 
and permeability. Dendrimers can work as a useful tool 
for optimizing drug delivery of such problematic drugs.  
Review concludes that there is need of some more 
research on effects of dendrimers to remove the 
ambiguity about the safety of dendrimers and to make 
them an excellent substitute for polymers in the future 
as it is one of the youngest and exciting fields of 
polymers researches, where all branches of science can 
take part and hence, deserves more intensive attention. 
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Table 1: Difference between Dendrimers and linear polymers 
Property  Dendrimers  Linear polymers  
Structure  Compact, Globular  Not compact  
Synthesis  Careful and stepwise 
growth  
Single step polycondensation  
Structural control  Very high  Low  
Shape  Spherical  Random coil  
Architecture  Regular  Irregular  
Non-polar solubility  High  Low  
Viscosity  Non linear relationship 
with molecular weight  
Linear relation with molecular 
weight  
Reactivity  High  Low  
Compressibility  Low  High  
Polydispersity  Monodisperse  Polydisperse  
Aqueous solubility  High  Low  
Crystallanity  
 
Non-crystalline, 
amorphous materials -
lower glass temperatures  
Semi crystalline/crystalline 
materials  
-Higher glass temperatures  
 
 
 
 
 
 
 
Table 2: Dendrimeric products available in markdet 
Product Application Company 
Vivagel Vaginal gel for HIV prevention Star Pharma 
Stratus CS Cardiac Marker Dade Behring 
Super Fect Gene Transfection Qiagen 
Alert ticket Anthrax Detection US Army Research 
Laboratory 
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Table 3: Techniques and methods for characterization of dendrimers 
1. Spectroscopy 
techniques
30 
a). NMR: Used for analysis of size, morphology and dynamics of 
dendrimers for organic dendrimers such ad ppi, polyphenylester. 
b). UV-Vis method: Used to monitor synthesis of dendrimers. 
c). Infra red spectroscopy: For routine analysis of the chemical 
transformations occurring at the surface of dendrimers. 
d). Fluorescence: To quantify defects during the synthesis of dendrimers. 
e). X-ray diffraction- For determination of the chemical composition, 
structure, size and shape of dendrimers. 
f). Raman spectroscopy gave relevant information about the degree of 
cyclodehydrogenation of polyphenylene dendrimers, and the characterization 
of PPI and dendrimers. 
g). Infra red spectroscopy (IR)- for routine analysis of the chemical 
transformations occurring at the surface of dendrimers. 
2. Microscopy
22 
 
Transmission microscopy and Scanning microscopy are mainly used for 
dendrimer analysis. 
3. 
Chromatography
25 
 
Size exclusive or gel permeation chromatography allows the separation of 
molecules according to size. 
4. Electrical 
techniques
31 
a). Electron paramagnetic resonance (EPR) Quantitative determination of the 
substitution efficiency on the surface of PANAM dendrimers. 
b). Electrochemistry gives information about the possibility of interaction of 
electroactive end groups. 
c). Electrophoresis used for the assessment of purify and homogeneity of 
several type of water soluble dendrimers. 
5. Rheology, 
physical 
properties
28 
 
a). Intrinsic viscosity- used as analytical probe of the morphological 
structure of dendrimers. 
b). Differential scanning calorimetry (DSC)- used to detect the glass 
transition temperature which depends on the moleculer weight, entangment 
and chain composition of polymers. 
c). Dielectric spectroscopy (DS)- gives information about molecular 
dynamic processes (α, β) 
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